stockrowNeogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Revenue growth
Neogen Corporation's revenue growth over the twelve months to 31 August 2026 was −0.33%, up 2.4 percentage points from fiscal 2026 (−2.72%). Over the past ten years it has ranged from −3.19% (fiscal 2025) to 56.0% (fiscal 2023); the current reading is higher than 17% of that period. That is below the Medical Devices industry median of 10.4% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | −2.72% | 0.47 |
| FY2025 | −3.19% | (15.56) |
| FY2024 | 12.4% | (43.64) |
| FY2023 | 56.0% | 43.48 |
| FY2022 | 12.5% | 0.50 |
| FY2021 | 12.0% | 11.07 |
| FY2020 | 0.96% | (3.13) |
| FY2019 | 4.09% | (6.98) |
| FY2018 | 11.1% | (0.45) |
| FY2017 | 11.5% | (1.98) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Aug 2026 | 6.50% | 6.57 |
| May 2026 | −0.07% | 4.36 |
| Feb 2026 | −4.43% | (1.59) |
| Nov 2025 | −2.84% | 0.74 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BFLY Butterfly Network, Inc. compare | 39.4% |
| ESTA Establishment Labs Holdings Inc. compare | 38.6% |
| TMDX TransMedics Group, Inc. compare | 28.5% |
| AXGN AxoGen, Inc. compare | 24.3% |
| UFPT UFP Technologies, Inc. compare | 8.62% |
| INSP Inspire Medical Systems, Inc. compare | −0.19% |
| ITGR Integer Holdings Corporation compare | −0.31% |
| NEOG Neogen Corporation | −0.33% |
| ALMR Alamar Biosciences, Inc. compare | — |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement